Arena Pharmaceuticals Inc
ARNA
ARNA was delisted on the 10th of March, 2022.
121 hedge funds and large institutions have $451M invested in Arena Pharmaceuticals Inc in 2014 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 34 increasing their positions, 39 reducing their positions, and 21 closing their positions.
6% less funds holding
Funds holding: 129 → 121 (-8)
13% less repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 39
28% less capital invested
Capital invested by funds: $628M → $451M (-$177M)
33% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 21
50% less call options, than puts
Call options by funds: $12.7M | Put options by funds: $25.4M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$7.74M |
| 2 |
DM
Deerfield Management
New York
|
+$6.6M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$5.24M |
| 4 |
State Street
Boston,
Massachusetts
|
+$4.13M |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$3.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$9.76M |
| 2 |
Norges Bank
Oslo,
Norway
|
-$8.62M |
| 3 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$2.96M |
| 4 |
Goldman Sachs
New York
|
-$2.76M |
| 5 |
Charles Schwab
San Francisco,
California
|
-$1.85M |
ARNA Hedge Fund Activity: Q3 2014 in Review
121 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q3 2014, worth a combined $451M — down 28% from $628M a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of ARNA and 14 opened new positions — a net loss of 7 holders — while 39 trimmed existing stakes and 34 added.
The largest buyer was Wellington Management Group, adding an estimated $7.74M. The largest seller was Morgan Stanley, cutting an estimated $9.76M.
- 121 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q3 2014, down from 129 in Q2 2014.
- Funds reported $451M of Arena Pharmaceuticals Inc stock for Q3 2014, down 28% quarter-over-quarter.
- 14 funds opened new Arena Pharmaceuticals Inc positions in Q3 2014 and 21 closed out, a net change of -7 holders.
- The largest Arena Pharmaceuticals Inc buyer in Q3 2014 was Wellington Management Group, an estimated $7.74M added.
- The largest Arena Pharmaceuticals Inc seller in Q3 2014 was Morgan Stanley, an estimated $9.76M sold.
Based on aggregated 13F filings for Q3 2014.